FDA Final Guidance On BPH Device Studies Suggests Swift Patient Follow-Up
Executive Summary
A new guidance document from the US agency strongly urges makers of medical devices for treating benign prostatic hyperplasia (BPH) – a common form of age-related prostate enlargement – to quickly conduct post-treatment evaluations as part of investigational studies.